Cell-free DNA Discoveries in Human Reproductive Medicine: Providing a New Tool for Biomarker and Genetic Assays in ART

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2021 Jan 9

PMID 33421023

Citations 2

Authors

Maryam Qasemi

Reza Mahdian

Fardin Amidi

Affiliations

Soon will be listed here.

Abstract

Cell-free DNAs (cfDNAs) are fragmented forms of DNA that are released into extracellular environments. Analyzing them, regarding either concentration or genetic/epigenetic status can provide helpful information about disorders, response to treatments, estimation of success rates, etc. Moreover, since they are presented in body fluids, evaluation of the aforementioned items would be achieved by less/non-invasive methods. In human reproduction field, it is required to have biomarkers for prediction of assisted reproduction techniques (ART) outcome, as well as some non-invasive procedures for genetic/epigenetic assessments. cfDNA is an appropriate candidate for providing the both approaches in ART. Recently, scientists attempted to investigate its application in distinct fields of reproductive medicine that resulted in discovering its applicability for biomarker and genetic/epigenetic analyses. However, due to some limitations, it has not reached to clinical administration yet. In this article, we have reviewed the current reported data with respect to advantages and limitations of cfDNA utilization in three fields of ART, reproduction of male and female, as well as in vitro developed embryos.

Citing Articles

Quantification of Free Circulating DNA and Differential Methylation Profiling of Selected Genes as Novel Non-Invasive Biomarkers for Endometriosis Diagnosis.

Benkhalifa M, Menoud P, Piquemal D, Hazout J, Mahjoub S, Zarquaoui M Biomolecules. 2025; 15(1).

PMID: 39858463 PMC: 11763320. DOI: 10.3390/biom15010069.

An Update on Non-invasive Approaches for Genetic Testing of the Preimplantation Embryo.

Kakourou G, Mamas T, Vrettou C, Traeger-Synodinos J Curr Genomics. 2023; 23(5):337-352.

PMID: 36778192 PMC: 9878856. DOI: 10.2174/1389202923666220927111158.

Global Trends in Research on Cell-Free Nucleic Acids in Obstetrics and Gynecology during 2017-2021.

Gao W, Yang H, Cheng W, Wang X, Li D, Shi B J Clin Med. 2022; 11(19).

PMID: 36233412 PMC: 9572904. DOI: 10.3390/jcm11195545.

References

Kustanovich A, Schwartz R, Peretz T, Grinshpun A . Life and death of circulating cell-free DNA. Cancer Biol Ther. 2019; 20(8):1057-1067. PMC: 6606043. DOI: 10.1080/15384047.2019.1598759. View

Thierry A, El Messaoudi S, Gahan P, Anker P, Stroun M . Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016; 35(3):347-76. PMC: 5035665. DOI: 10.1007/s10555-016-9629-x. View

Barrett A, Thadani H, Laureano-Asibal C, Ponnusamy S, Choolani M . Stability of cell-free DNA from maternal plasma isolated following a single centrifugation step. Prenat Diagn. 2014; 34(13):1283-8. DOI: 10.1002/pd.4468. View

Olsen J, Kenna L, Tipon R, Spelios M, Stecker M, Akirav E . A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis. EBioMedicine. 2016; 10:227-35. PMC: 5006601. DOI: 10.1016/j.ebiom.2016.06.031. View

Lo Y, Tein M, Lau T, Haines C, Leung T, Poon P . Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998; 62(4):768-75. PMC: 1377040. DOI: 10.1086/301800. View

Lo Y . Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem. 2000; 46(12):1903-6. View

Norton M, Jacobsson B, Swamy G, Laurent L, Ranzini A, Brar H . Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015; 372(17):1589-97. DOI: 10.1056/NEJMoa1407349. View

Stigliani S, Anserini P, Venturini P, Scaruffi P . Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum Reprod. 2013; 28(10):2652-60. DOI: 10.1093/humrep/det314. View

Chen Y, Liao T, Zhu L, Lin X, Wu R, Jin L . Seminal plasma cell-free mitochondrial DNA copy number is associated with human semen quality. Eur J Obstet Gynecol Reprod Biol. 2018; 231:164-168. DOI: 10.1016/j.ejogrb.2018.10.048. View

10.

Pourmasumi S, Sabeti P, Rahiminia T, Mangoli E, Tabibnejad N, Talebi A . The etiologies of DNA abnormalities in male infertility: An assessment and review. Int J Reprod Biomed. 2017; 15(6):331-344. PMC: 5605854. View

11.

Papachristou F, Simopoulou M, Touloupidis S, Tsalikidis C, Sofikitis N, Lialiaris T . DNA damage and chromosomal aberrations in various types of male factor infertility. Fertil Steril. 2007; 90(5):1774-81. DOI: 10.1016/j.fertnstert.2007.09.006. View

12.

Menezo Y . Paternal and maternal factors in preimplantation embryogenesis: interaction with the biochemical environment. Reprod Biomed Online. 2006; 12(5):616-21. DOI: 10.1016/s1472-6483(10)61188-1. View

13.

Kort D, Chia G, Treff N, Tanaka A, Xing T, Vensand L . Human embryos commonly form abnormal nuclei during development: a mechanism of DNA damage, embryonic aneuploidy, and developmental arrest. Hum Reprod. 2015; 31(2):312-23. DOI: 10.1093/humrep/dev281. View

14.

Chou J, Jacobson J, Patton W, King A, Chan P . Modified isocratic capillary electrophoresis detection of cell-free DNA in semen. J Assist Reprod Genet. 2005; 21(11):397-400. PMC: 3455857. DOI: 10.1007/s10815-004-7527-6. View

15.

Li H, Huang S, Zhou H, Liao A, Xiong C . Quick recovery and characterization of cell-free DNA in seminal plasma of normozoospermia and azoospermia: implications for non-invasive genetic utilities. Asian J Androl. 2009; 11(6):703-9. PMC: 3735333. DOI: 10.1038/aja.2009.65. View

16.

Bronkhorst A, Ungerer V, Holdenrieder S . The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019; 17:100087. PMC: 6425120. DOI: 10.1016/j.bdq.2019.100087. View

17.

Costa F, Barbisan F, Assmann C, Araujo N, de Oliveira A, Signori J . Seminal cell-free DNA levels measured by PicoGreen fluorochrome are associated with sperm fertility criteria. Zygote. 2017; 25(2):111-119. DOI: 10.1017/S0967199416000307. View

18.

Wu C, Ding X, Li H, Zhu C, Xiong C . Genome-wide promoter methylation profile of human testis and epididymis: identified from cell-free seminal DNA. BMC Genomics. 2013; 14:288. PMC: 3653781. DOI: 10.1186/1471-2164-14-288. View

19.

Wu C, Ding X, Tan H, Li H, Xiong C . Alterations of testis-specific promoter methylation in cell-free seminal deoxyribonucleic acid of idiopathic nonobstructive azoospermic men with different testicular phenotypes. Fertil Steril. 2016; 106(6):1331-1337. DOI: 10.1016/j.fertnstert.2016.07.006. View

20.

Gunes S, Arslan M, Hekim G, Asci R . The role of epigenetics in idiopathic male infertility. J Assist Reprod Genet. 2016; 33(5):553-569. PMC: 4870443. DOI: 10.1007/s10815-016-0682-8. View